Can the ROX index predict high-flow nasal cannula failure in children under 2 with lower respiratory tract infection?

Vásquez PabloAlvaro L Jacome-OrozcoAndrea P Rodriguez-MayorgaLeidy E Sepulveda-ForeroDiana P Escobar-SernaJuan S BarajasEvelyn Obando-BelalcazarClaudia M Salinas-JaimesJuan J Peralta-PalmezanoAlexandra Jimenez-ChavezRafael E Camacho-JimenezJesus A Dominguez-Rojas

Published in: Pediatric pulmonology (2024)

While the ROX index is associated with HFNC outcomes in children under 2 years, its predictive ability is modest, impacted by significant variability among patients, physicians, and centers. These findings emphasize the need for more reliable predictive tools for HFNC therapy in this patient population.

Keyphrases

respiratory tract
young adults
primary care
extracorporeal membrane oxygenation
intensive care unit
metabolic syndrome
bone marrow
mesenchymal stem cells
weight loss